Trial intelligence / Profile preview

Intranasal ketamine versus intravenous morphine for acute renal colic pain in emergency patients

IRCT20121010011067N4Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of ketamine and morphine in Renal colic (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Pain score at 15 minutes, Pain score at 30 minutes and 1 more. Started May 2019; status: completed.

02

Drugs

ketaminemorphine
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20121010011067N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20121010011067N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call